Just Published
Webinar
What’s Next for PPD Treatment | Inhaled Mebufotenin (GH001) Phase 2a Results
July 29, 2026
Kristina Deligiannidis, MD, presents phase 2a results for inhaled GH001 (mebufotenin), a psychedelic-based therapeutic that produced same-day remission of postpartum depression in an open-label trial, with rapid clearance from…
Original Research
The Journal of Clinical Psychiatry
The Journal of Clinical Psychiatry is a leader in peer-reviewed articles on mental health topics for psychiatrists and medical professionals. Now featuring The JCP Podcast: conversations with experts exploring the research shaping clinical care.
EXPLORE JCP
Original Research
GLP-1 Receptor Agonists and Overdose Risk in Veterans with Type 2 Diabetes and Opioid Use Disorder
July 15, 2026
Semaglutide and tirzepatide were associated with lower risk of all-cause overdose compared to insulin and SGLT2i inhibitors, but not metformin, sulfonylureas, or DPP4 inhibitors.
The Primary Care Companion for CNS Disorders
The Primary Care Companion for CNS Disorders seeks to advance the clinical expertise of primary care physicians and other health care professionals who treat patients with mental and neurologic illnesses.
View PCC Articles
